Rajest et al17 studied the correlation between VEGF and CD31 in breast cancer cells and found no correlation between these 2 markers; they concluded that multiple angiogenic factors must play a role together with VEGF in the angiogenic process. Here, PECAM1 is linked to breast carcinoma.